Literature DB >> 1702729

Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor.

S Yoshino1, E Schlipköter, R Kinne, T Hünig, F Emmrich.   

Abstract

Adjuvant arthritis (AA) in rats is an experimentally induced autoimmune disease mediated by T lymphocytes specific for Mycobacterium tuberculosis. We raised the question whether T cells carrying the gamma/delta T cell receptor (TcR), reactive or not to mycobacterial antigens, are involved in the pathogenesis of AA. For this purpose, T cells bearing the TcR alpha/beta were depleted from circulation by treatment with a monoclonal antibody against the rat TcR alpha/beta (R73). This treatment efficiently suppressed existing disease. Even more efficient was pretreatment with R73 from birth, which prevented AA induction completely. In these alpha/beta+ T cell-depleted animals an elevated level of alpha/beta- T cells (about 15% vs. 1% in normal rats) was evident, which was not significantly increased by Mycobacterium tuberculosis injection. We found no positive evidence that gamma/delta + T cells do contribute to AA induction. Moreover, treatment with an anti-TcR alpha/beta monoclonal antibody may be very efficient treatment of T cell-mediated autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702729     DOI: 10.1002/eji.1830201241

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  The role of gamma delta T cells in the normal and disordered immune system.

Authors:  B Bröker; P M Lydyard; F Emmrich
Journal:  Klin Wochenschr       Date:  1990-05-17

2.  Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.

Authors:  J C Hoffmann; C Herklotz; H Zeidler; B Bayer; H Rosenthal; J Westermann
Journal:  Ann Rheum Dis       Date:  1997-12       Impact factor: 19.103

3.  Immunohistochemical study of lymphoid tissues in adjuvant arthritis (AA) by image analysis; relationship with synovial lesions.

Authors:  M Carol; C Pelegrí; C Castellote; A Franch; M Castell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

4.  A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1).

Authors:  A S Hansson; D Heinegård; R Holmdahl
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.

Authors:  Xiaolei Tang; David E Yocum; David Dejonghe; Kathryn Nordensson; Douglas F Lake; John Richard
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

6.  Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium.

Authors:  W V Williams; Q Fang; D Demarco; J VonFeldt; R B Zurier; D B Weiner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Arthritis in Lewis rats induced by the non-immunogenic adjuvant CP20961: an immunohistochemical analysis of the developing disease.

Authors:  S C Meacock; D R Brandon; M E Billingham
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

8.  In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat.

Authors:  J Reynolds; C D Pusey
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.

Authors:  Y Matsumoto; M Tsuchida; H Hanawa; T Abo
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

10.  Anti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditis.

Authors:  H Hanawa; M Kodama; T Inomata; T Izumi; A Shibata; M Tuchida; Y Matsumoto; T Abo
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.